Increasing trend in infection-related death-censored graft failure in renal transplantation

Transplantation

Volumn 91, Issue 1, 2011, Pages 94-99

  Parasuraman, Ravi ^a   Abouljoud, Marwan ^b   Jacobsen, Gordan ^b   Reddy, Gampala ^a   Koffron, Alan ^a   Venkat, K K ^b  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

^b HENRY FORD HOSPITAL   (United States)

Author keywords

Graft failure; Infection; Kidney transplantation

Indexed keywords

ADULT; ARTICLE; CHI SQUARE TEST; CONTROLLED STUDY; DEATH CENSORED GRAFT FAILURE; FEMALE; GRAFT FAILURE; GRAFT INFECTION; GRAFT RECIPIENT; HUMAN; INFECTION RISK; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; POLYOMAVIRUS INFECTION; PRIORITY JOURNAL; RANK SUM TEST; RECURRENT DISEASE; STUDENT T TEST;

ADULT; AGED; COMMUNICABLE DISEASES; FEMALE; GRAFT REJECTION; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POLYOMAVIRUS INFECTIONS; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; RISK FACTORS; UROLOGIC DISEASES;

EID: 78751641371     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181fdd96c     Document Type: Article

References (33)

1. Wolfe RA, Ashby VB, Milford EL, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 1999;341:1725.
2. McDonald SP, Russ GR. Survival of recipients of cadaveric kidney transplants compared with those receiving dialysis treatment in Australia and New Zealand, 1991-2001. Nephrol Dial Transplant 2002;17:2212.
3. Hariharan S, Johnson CP, Bresnahan BA, et al. Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med 2000;342:605.
4. Meier-Kriesche HU, Schold JD, Srinivas TR, et al. Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. Am J Transplant 2004;4:378.
5. Annual Data Report. Atlas of chronic kidney disease and end stage renal disease in the United States. Am J Kidney Dis 2008;51: S1.
6. Womer KL, Kaplan B. Recent developments in kidney transplantation-A critical assessment. Am J Transplant 2009;9:1265.
7. El-Zoghby ZM, Stegall MD, Lager DJ, et al. Identifying specific causes of kidney allograft loss. Am J Transplant 2009;9:527.
8. Jevnikar AM, Mannon RB. Late kidney allograft loss: What we know about it, and what we can do about it. Clin J Am Soc Nephrol 2008;3(suppl 2): S56.
9. Ojo AO, Hanson JA, Wolfe RA, et al. Long-term survival in renal transplant recipients with graft function. Kidney Int 2000;57:307.
10. Chang SH, Russ GR, Chadban SJ, et al. Trends in kidney transplantation in Australia and New Zealand, 1993-2004. Transplantation 2007;84:611.
11. Diethelm AG, Deierhoi MH, Hudson SL, et al. Progress in renal transplantation: A single center study of 3359 patients over 25 years. Ann Surg 1995;221:446.
12. Excerpts from the United States Renal Data System 2008 annual data report, transplantation. Am J Kidney Dis 2009;53(suppl 1): S228.
13. Pirsh JD, Miller J, Dierhoi MH, et al. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group. Transplantation 1997;63:977.
14. Kahan BD. Efficacyofsirolimus compared with azathioprine for reduction of acute allograft rejection: A randomised multicentre study. The Rapamune US Study Group. Lancet 2000;356:194.
15. MacDonald AS, for the Rapamune Global Study Group. A worldwide, phase III, randomized, controlled, safety and efficacy study of a siroli-mus/ cyclosporine regimen for prevention of acute rejection in recipients of primary mismatched renal allografts. Transplantation 2001;71:271.
16. Dharnidharka VR, Caillard S, Agodoa LY, et al. Infection frequency and profile in different age groups of kidney transplant recipients. Transplantation 2006;81:1662.
17. Dharnidharka VR, Agodoa LY, Abbott KC. Risk factors for hospitaliza-tion for bacterial or viral infection in renal transplant recipients: An analysis of USRDS data. Am J Transplant 2007;7:653.
18. Byrd LH, Tapia L, Cheigh JS, et al. Association between Streptococcus faecalis urinary tract infections and graft rejection in kidney transplantation. Lancet 1978;2:1167.
19. Simmons RL, Weil R, Tallent MB, et al. Do mild infections trigger the rejection of renal allografts? Transplant Proc 1970;2:419.
20. Heemann UW, Tullius SG, Schmid C, et al. Infection associated cellular activation accelerates chronic renal allograft rejection in rats. Transpl Int 1996;9:137.
21. Opelz G, Dohler B, Ruhenstroth A. Cytomegalovirus prophylaxis and graft outcome in solid organ transplantation: A collaborative transplant study report. Am J Transplant 2004;4:928.
22. Randhawa PS, Magnone M, Jordan M, et al. Renal allograft involvement by Epstein-Barr virus associated post-transplant lymphoprolif-erative disease. Am J Surg Pathol 1996;20:563.
23. Hirsch HH, Knowles W, Dickenmann M, et al. Prospective study of polyomavirus typeBK replication and nephropathy inrenal-transplant recipients. N Engl J Med 2002;347:488.
24. Hariharan S. BK virus nephritis after renal transplantation. Kidney Int 2006;69:655.
25. Dall A, Hariharan S. BK virus nephritis after renal transplantation. Clin J Am Soc Nephrol 2008;3(suppl 2): S68.
26. Sagedal SS, Hartmann A. Cytomegalovirus infectioninrenal transplant recipients is associated with impaired survival irrespective of expected mortality risk. Clin Transplant 2007;21:309.
27. Hartmann A, Sagedal S, Hjetmesaeth J. The natural course of cytomeg-alovirus infection and disease in renal transplant recipients. Transplantation 2006;82: S15.
28. Mattoso R, Khouri N, de Jesus L, et al. Risk factors for graft dysfunction in the late period of renal transplantation. Transplant Proc 2009;41:1594.
29. Witzke O, Schmidt C, Kohnle M, et al. Impact of febrile infections on the long-term function of kidney allografts. J Urol 2001;166:2048.
30. Häyry P, Mennander A, Yilmaz S, et al. Towards understanding the pathophysiology of chronic rejection. Clin Investig 1992;70:780.
31. Kutinova A, Woodward RS, Ricci JF, et al. The incidence and costs of sepsis and pneumonia before and after renal transplantation in the United States. Am J Transplant 2006;6:129.
32. Pourmand G, Pourmand M, Salem S, et al. Posttransplant infectious complications: A prospective study on 142 kidney allograft recipients. Urol J 2006;3:23.
33. Manitpisitkul W, McCann E, Lee S, et al. Drug interactions in transplant patients: What everyone should know. Curr Opin Nephrol Hyper-tens 2009;18:379.